AERT vs FLUX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AERT exhibits severe financial distress, as reflected in its Piotroski F-Score of 2/9, indicating weak operational and financial health. The absence of an Altman Z-Score and negative Price/Book ratio (-17.09) signal deep value distortion and potential insolvency risk. Despite a modest gross margin of 24.91%, the company reports negative profit margins (-4.22%) and declining revenue and earnings (YoY -0.80% and -67.80%, respectively). Insider selling of $0.06M over six months further undermines confidence, while the stock has lost over 95% of its value over five years. These factors collectively point to a high-risk, fundamentally deteriorating business.
FLUX exhibits severe financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. The company is suffering from shrinking revenue (-16.10% YoY) and a catastrophic ROE of -211.67%, suggesting significant value destruction for shareholders. Despite a positive gross margin, the stock is in a precipitous technical decline, losing over 81% of its value in the last six months. The massive disconnect between the analyst target price ($5.33) and the current market price ($1.08) suggests a failure of analyst models to account for the company's deteriorating fundamentals.
Compare Another Pair
Related Comparisons
AERT vs FLUX: Head-to-Head Comparison
This page compares Aeries Technology, Inc (AERT) and Flux Power Holdings, Inc. (FLUX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.